What caused the CLTN.SW stock drop on 16 Jan 2026?

CLTN.SW stock fell **7.06%** on 16 Jan 2026 due to heavy profit-taking, a volume spike to **19,409** and a pullback from recent highs. No specific company announcement drove the move; technical selling and rotation in the healthcare group were the likely drivers.

Is CLTN.SW stock a buy after the decline?

Meyka AI currently scores CLTN.SW as **B (HOLD)**. The stock offers a dividend yield near **4.63%**, but the 12-month model projects **CHF47.58**, implying downside. Consider earnings, liquidity needs and risk tolerance before buying.

What are the key financials to watch for CLTN.SW stock?

Monitor EPS (**CHF2.40**), PE (**22.50**), dividend per share (**CHF2.50**), inventory turn and cash conversion cycle. Watch debt-to-equity (**0.56**) and operating margin changes around the next earnings release on 06 Mar 2026.

How does the Meyka AI forecast affect CLTN.SW stock outlook?

Meyka AI's model projects monthly **CHF59.38** and quarterly **CHF61.46**, implying near-term upside. These are statistical projections, not guarantees. Use them alongside fundamentals, sector trends and the upcoming earnings report.

CH Stocks

CLTN.SW COLTENE Holding AG (SIX) down 7.06% at close 16 Jan 2026: market signals

ByHuzaifa Zahoor January 17, 2026January 17, 2026

CLTN.SW stock slid 7.06% to CHF54.00 at the market close on 16 Jan 2026 on the SIX in Switzerland, making it one of the day’s top losers. Volume spiked to 19,409 shares, about 3.09x the average, signaling heavy selling. Traders reacted to profit-taking near the 52-week high and a sharp intraday gap from CHF58.10 to CHF54.00. We review valuation, technicals, Meyka AI grade and short-term forecasts to frame trading and investment choices for COLTENE Holding AG (CLTN.SW).